Literature DB >> 7986064

Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein.

J P Thomas1, B Kalyanaraman, A W Girotti.   

Abstract

Oxidative modification of human low-density lipoprotein (LDL) is thought to play an important role in the development of atherosclerosis. LDL oxidizability is believed to be strongly influenced by factors such as (a) content of preexisting lipid hydroperoxides (LOOHs) and (b) content of endogenous antioxidants such as alpha-tocopherol and beta-carotene. The purpose of this study was to examine the prooxidant role of preexisting LDL-LOOHs, using a recently developed method for ultrasensitive and selective LOOH analysis: high-performance liquid chromatography with mercury drop electrochemical detection (HPLC-EC). Exceedingly low detection limits for LDL-LOOHs have been achieved by HPLC-EC, e.g., approximately 100 fmol for cholesteryl ester hydroperoxide (CEOOH). This sensitivity has allowed us to monitor LDL-LOOHs at levels that are undetectable by most other methods. Fresh LDL prepared with the utmost care to prevent autoxidation was found to contain small, yet significant amounts of CEOOH, 6-12 pmol/mg protein. Our data suggest that these peroxides could not have arisen during LDL isolation or sample work-up for HPLC-EC. Incubation with GSH and phospholipid hydroperoxide glutathione peroxidase resulted in nearly complete reduction of the CEOOH. This LDL was found to be much more resistant to Cu(2+)-induced peroxidation than starting material, exhibiting a lag period that was at least six times greater. We have also determined that LDL becomes progressively more susceptible to Cu(2+)-induced lipid peroxidation (as evidenced by a shortened lag) when it is preloaded with increasing amounts of photochemically generated LOOHs. Taken together, these results provide strong support for the idea that preexisting LOOHs in LDL are important determinants of its overall oxidizability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986064     DOI: 10.1006/abbi.1994.1496

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease.

Authors:  R L Walzem; S Watkins; E N Frankel; R J Hansen; J B German
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

3.  Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis.

Authors:  Sylas B Cappi; Danilo T Noritomi; Irineu T Velasco; Rui Curi; Tatiana C A Loureiro; Francisco G Soriano
Journal:  Intensive Care Med       Date:  2012-02-02       Impact factor: 17.440

4.  Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein.

Authors:  R P Patel; D Svistunenko; M T Wilson; V M Darley-Usmar
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 5.  Translocation as a means of disseminating lipid hydroperoxide-induced oxidative damage and effector action.

Authors:  Albert W Girotti
Journal:  Free Radic Biol Med       Date:  2007-12-15       Impact factor: 7.376

6.  Cholesterol as a natural probe for free radical-mediated lipid peroxidation in biological membranes and lipoproteins.

Authors:  Albert W Girotti; Witold Korytowski
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-12-28       Impact factor: 3.205

7.  Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations.

Authors:  J Nourooz-Zadeh; J Tajaddini-Sarmadi; K L Ling; S P Wolff
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

8.  Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

Authors:  Cecilia Morgantini; Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Diabetes       Date:  2010-09-08       Impact factor: 9.461

9.  Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism.

Authors:  Roberto Arriga; Francesca Pacifici; Barbara Capuani; Andrea Coppola; Augusto Orlandi; Maria Giovanna Scioli; Donatella Pastore; Aikaterini Andreadi; Paolo Sbraccia; Manfredi Tesauro; Nicola Di Daniele; Giuseppe Sconocchia; Giulia Donadel; Alfonso Bellia; David Della-Morte; Davide Lauro
Journal:  Oxid Med Cell Longev       Date:  2019-12-19       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.